The gene for the human dolichol cycle GlcNAc-1-P transferase (ALG7/GPT) was cloned by screening a human lung fibroblast cDNA library. The library was constructed in a Saccharomyces cerevisiae expression vector, and the positive clone was identified by complementation of the conditional lethal S.cerevisiae strain YPH-A7-GAL. This strain was constructed by replacing the endogenous promoter of the GPT-gene by the stringently regulated GAL1-promoter. This construct allows to specifically suppress the endogenous enzyme activity. The insert of the positive clone displayed an open reading frame of 1200 nucleotides, coding for a putative protein of 400 amino acids with a calculated molecular weight of 44.7 kDa. The deduced protein sequence shows a homology of over 90% when compared with other mammalian GPT sequences, thus resembling the close phylogenetic relationship between mammalian species. This homology however decreases to 40-50% when compared to more distantly related organisms such as S.cerevisiae , Schizosaccharomyces pombe , or Leishmania amazonensis . Biochemical characterization of the recombinant protein showed that it is functionally expressed in the S.cerevisiae strain YPH-A7-GAL. GlcNAc- and GlcNAc2-PP-Dolichol biosynthesis could be shown with isolated S.cerevisiae membranes from cells harboring the recombinant plasmid and grown on glucose thus suppressing transcription of the endogenous gene. Synthesis could be stimulated by dolicholphosphate and was inhibited by tunicamycin. These results show that we have cloned the human GlcNAc-1-P transferase by heterologous complementation in S. cerevisiae, a strategy that may be useful for the cloning and characterization of glycosyltransferases from a variety of organisms.

Download full-text PDF

Source
http://dx.doi.org/10.1093/glycob/8.1.77DOI Listing

Publication Analysis

Top Keywords

glcnac-1-p transferase
12
human glcnac-1-p
8
dolichol cycle
8
heterologous complementation
8
saccharomyces cerevisiae
8
positive clone
8
scerevisiae strain
8
strain yph-a7-gal
8
cloning functional
4
functional expression
4

Similar Publications

N-glycosylation, a common post-translational modification, is widely acknowledged to have a significant effect on protein stability and folding. N-glycosylation is a complex process that occurs in the endoplasmic reticulum (ER) and requires the participation of multiple enzymes. GlcNAc-1-P-transferase (GPT) is essential for initiating N-glycosylation in the ER.

View Article and Find Full Text PDF

Exploring the Active Site of the Antibacterial Target MraY by Modified Tunicamycins.

ACS Chem Biol

November 2020

Structure, Biophysics and FBLG, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.

The alarming growth of antibiotic resistance that is currently ongoing is a serious threat to human health. One of the most promising novel antibiotic targets is MraY (phospho-MurNAc-pentapeptide-transferase), an essential enzyme in bacterial cell wall synthesis. Through recent advances in biochemical research, there is now structural information available for MraY, and for its human homologue GPT (GlcNAc-1-P-transferase), that opens up exciting possibilities for structure-based drug design.

View Article and Find Full Text PDF

Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax.

Antimicrob Agents Chemother

August 2020

Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, Department of Genetics, Evolution, Microbiology and Immunology, University of Campinas-UNICAMP, Campinas, São Paulo, Brazil

Article Synopsis
  • - Widespread resistance to current antimalarial drugs has sparked the urgent need for new effective treatments, leading researchers to explore drug repositioning as a cost-effective strategy.
  • - A computer-assisted drug repositioning approach identified seven promising drug candidates, with epirubicin being highlighted for further testing due to its strong effectiveness against both drug-sensitive and resistant malaria strains.
  • - Experimental validation revealed that epirubicin not only kills malaria parasites but also blocks their transmission, and further studies aim to understand its mechanism of action, suggesting it could be optimized for use in malaria treatment.
View Article and Find Full Text PDF

Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.

J Mol Biol

August 2020

Department of Biochemistry, Duke University Medical Center, 303 Research Drive,Durham, NC 27710, USA. Electronic address:

The widespread emergence of antibiotic resistance in pathogens necessitates the development of antibacterial agents inhibiting underexplored targets in bacterial metabolism. One such target is phospho-MurNAc-pentapeptide translocase (MraY), an essential integral membrane enzyme that catalyzes the first committed step of peptidoglycan biosynthesis. MraY has long been considered a promising candidate for antibiotic development in part because it is the target of five classes of naturally occurring nucleoside inhibitors with potent in vivo and in vitro antibacterial activity.

View Article and Find Full Text PDF

We showed previously that the Y97N mutant of the ST0452 protein, isolated from , exhibited over 4 times higher -acetylglucosamine-1-phosphate (GlcNAc-1-P) uridyltransferase (UTase) activity, compared with that of the wild-type ST0452 protein. We determined the three-dimensional structure of the Y97N protein to explore the detailed mechanism underlying this increased activity. The overall structure was almost identical to that of the wild-type ST0452 protein (PDB ID 2GGO), with residue 97 (Asn) interacting with the O-5 atom of -acetylglucosamine (GlcNAc) in the complex without metal ions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!